AR and posterior cortical atrophy: Therefore, targeting AR activity through androgen deprivation therapy or anti-androgens (AA, e.g., enzalutamide) has become a vital treatment approach for managing metastatic PCa, offering a promising strategy to address this aggressive and often deadly disease [15].